Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
1.1 ML elranatamab-bcmm 40 MG/ML Injection [Elrexfio]
40 MG/ML · Injection · injection
A form of elranatamab-bcmm →
1.1 ML elranatamab-bcmm 40 MG/ML Injection [Elrexfio] — Other monoclonal antibodies and antibody drug conjugates. Strength, form, class, interactions & more.
![1.1 ML elranatamab-bcmm 40 MG/ML Injection [Elrexfio]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aa044060-5b4b-4692-bf0f-9a50e140b10e&name=elranatamab-01.jpg)
Active ingredient
Classification
Drug interactions
Elranatamab-bcmm may affect the metabolism of certain CYP substrates, leading to increased exposure and potential toxicity.
- moderateCYP substrates — increased exposure leading to serious adverse reactions
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication